Mazumdar Shaw’s contribution will be part of the initial funding pool for the research projects on ‘Pandemic Preparedness’. These projects support national efforts in preparing for and responding to future pandemics. A key goal will be to build competencies that will enable India to mount a quick and effective response to future pandemics, said an Ignite Life Science Foundation release.
Swami Subramaniam, CEO, Ignite Life Science, said, “I welcome Mazumdar Shaw’s contribution and, on behalf of the Board at Ignite, I wish to express our profound gratitude for her generosity towards this cause. Her contribution will help Ignite get started in a meaningful way towards generating proof of principle for our long-term mission, which is to help create and sustain a robust environment that promotes world-class scientific research and productivity here in India. We hope our work will bring conversations about science into the mainstream and help grow philanthropic funding for scientific research to solve challenging health problems facing the country.”
The Foundation has been incorporated at Bangalore, Karnataka, as a Section 8 firm under the Indian Companies Act. The Foundation is creating a corpus through endowments, contributions from individuals & institutional donors, apart from Alliance partners. The Foundation has been created and is managed by a group of professionals who believe in the cause of science for India. These professionals are drawn from various fields, particularly, scientific research, academia and management.
Dr. Pankaj Chandra currently is a Professor, Vice Chancellor and Chairman of the Board of Governors of Ahmedabad University.
Prof. S. Ramaswamy is Professor of Biological Sciences & Biomedical Engineering; Director, Bindley Bioscience Center at Purdue University.
Dr. Jyotsna Dhawan retired scientist from CCMB
Dr. Gagandeep Kang is MD PhD from CMC Vellore and a Fellow of the Royal College of Pathologists.
Dr. Shahid Jameel is the Chief Executive Officer of The Wellcome Trust/DBT India Alliance since 2013.
Dr. Anand Anandkumar is a PhD in Electrical and Biomedical Engineering and
Dr. Swami Subramaniam is a physician who has trained as a clinical pharmacologist
